|
|
|
|
|
|
|
Allied Healthcare Products Inc. (AHPI)
|
|
2.02 -0.07 (-3.35%)
|
10-17 15:30
|
|
Open:
|
2.02
|
Pre. Close:
|
2.09
|
|
High:
|
2.029
|
Low:
|
2.01
|
|
Volume:
|
1,802
|
Market Cap:
|
8M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
2.031 - 2.042
|
2.042 - 2.049
|
|
Low:
|
1.986 - 1.997
|
1.997 - 2.005
|
|
Close:
|
2.003 - 2.021
|
2.021 - 2.035
|
|
|
|
Technical analysis (as of: 2018-10-17 4:31:20 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.
|
|
Target:
|
Six months: 2.67 One year: 2.86
|
|
Support:
|
Support1: 2.01 Support2: 1.67
|
|
Resistance:
|
Resistance1:
2.28 Resistance2: 2.45
|
|
Pivot:
|
2.15
|
|
Moving Averages:
|
MA(5): 2.05 MA(20): 2.19
MA(100): 2.39 MA(250): 2.42 
|
|
MACD:
|
MACD(12,26):
-0.07 Signal(12,26,9): -0.06
|
|
%K %D:
|
%K(14,3): 10.86 %D(3): 8.76
|
|
RSI:
|
RSI(14): 37.98
|
|
52-Week:
|
High: 5.25
Low: 1.72 Change(%): 3.6
|
|
Average Vol(K):
|
3-Month: 610
10-Days 413
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.AHPI has closed above bottom band by 12.4%. Bollinger Bands are 7.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
2017-11-27T11:02:28-05:00
Allied Healthcare Products up 22%
2017-11-24T12:17:17-05:00
Midday Gainers / Losers
2017-09-22T11:52:37-04:00
Your Daily Pharma Scoop: VanEck Vectors Biotech ETF, Esperion's Growth Potential, Pfizer's EU Approval
2017-09-21T11:36:29-04:00
Your Daily Pharma Scoop: Intercept's Buy Opportunity, Alcobra's Downfall, Shire's Japanese Approval
2017-09-20T11:31:29-04:00
Your Daily Pharma Scoop: Geron's Growth Potential, Ipsen's Xarmelo Approval, GSK's Ellipta Approved
2017-09-19T17:17:26-04:00
Your Daily Pharma Scoop: Nabriva's Further Potential, Allergan's IP Gimmick, Supernus's Positive Data
2016-09-19T14:11:34-04:00
The Micro-Cap Digest: A Net-Net Approach
2016-04-04T13:04:00-04:00
New York Appellate Court Rules Against Allied Healthcare Products in Stuyvesant Falls Power Covenant Lawsuit
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
